Atlas Trials

Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease

Clinical trial NCT07348250 · TERMINATED

Trial details

NCT number
NCT07348250
Sponsor
Invicro
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Parkinson's Disease (PD)Parkinson's DiseaseParkinson's Disease (Disorder)
Start date
2025-12-08
Primary completion
2026-03-26
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.